Back to news
REGULATORYMarijuana Moment

Nebraska says medical cannabis testing has no established timeline

Nebraska's Medical Cannabis Commission clarified that it has not set a timeline for product testing, acknowledging that the uncertainty creates planning and financial problems for licensed cultivators. The gap shows Oklahoma operators and regulators how testing authority, transport rules and fee design can become supply-chain bottlenecks in a new medical market.

Share this update

FacebookXLinkedInEmail

#other-state#nebraska#testing#compliance#licensing

Read the original source

Leafy summaries provide industry context. Confirm details with Marijuana Moment.

Open source

Continue reading

Related industry updates